SCHEMBL4889959

SCHEMBL4889959

CC(C)CCCCCC(=O)OCCOC(=O)CCCCCC(C)C

nearest known ligand 0.61

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
DGKA P23743 1/20 0.61
MAPT P10636 1/20 0.47
DNM1 Q05193 1/20 0.46
KDM4C Q9H3R0 2/20 0.43
ALDH1A1 P00352 2/20 0.43
KDM4A O75164 1/20 0.43
PHF8 Q9UPP1 1/20 0.43
KDM2A Q9Y2K7 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
LMNA P02545 3/20 0.42
CYP3A4 P08684 1/20 0.42
TSHR P16473 1/20 0.42
ATM Q13315 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
PAM P19021 2/20 0.41
KDM4E B2RXH2 1/20 0.41
DUSP3 P51452 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL149453 1.00 DGKA (0.61) DGKAMAPTDNM1KDM4CALDH1A1
SCHEMBL1278461 1.00 DGKA (0.61) DGKAMAPTDNM1KDM4CALDH1A1
SCHEMBL1011923 0.98 DGKA (0.57) DGKAMAPTDNM1KDM4CALDH1A1
SCHEMBL2396997 0.94 DGKA (0.53) DGKAMAPTDNM1KDM4CALDH1A1
SCHEMBL50203 0.94 DGKA (0.53) DGKAMAPTDNM1KDM4CALDH1A1
SCHEMBL8961837 0.94 DGKA (0.53) DGKAMAPTDNM1KDM4CALDH1A1
SCHEMBL17812626 0.94 DGKA (0.53) DGKAMAPTDNM1KDM4CALDH1A1
SCHEMBL494789 0.94 DGKA (0.53) DGKAMAPTDNM1KDM4CALDH1A1
SCHEMBL494994 0.94 DGKA (0.53) DGKAMAPTDNM1KDM4CALDH1A1
SCHEMBL33694 0.94 DGKA (0.53) DGKAMAPTDNM1KDM4CALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080138368-A1 ANHYDROUS CARE OF MAKE-UP COMPOSITION CONTAINING FIBERS AND POLYOLS L'OREAL S.A. 2008-06-12 US claimed
US-20060057085-A1 Anhydrous care or make-up composition containing fibers and polyols L'OREAL S.A. 2006-03-16 US claimed
US-4673569-A FILM FORMING POLYVINYLPYRROLIDONE WITH DIESTER OF DIETHYLENE GLYCOL AND SODIUM BENZOATE FABERGE INCORPORATED (US) 1987-06-16 US claimed
CN-114828812-B Composition comprising extracts of stems and axillary buds of rose shrubs 欧莱雅 2025-04-25 CN disclosed
EP-3870309-B1 MINERAL SUNSCREEN COMPOSITIONS WITH IMPROVED EFFICACY OREAL (FR) 2024-07-03 EP disclosed
WO-2023117955-A1 COMPOSITION COMPRISING AN UNMODIFIED CLAY, A MAGNESIUM SALT, AN ALPHA-HYDROXY ACID AND WATER L'OREAL (FR) 2023-06-29 WO disclosed
US-20220401761-A1 Skin External Preparation for Cellulite Improvement and Cellulite Improvement Method TOYO SUGAR REFINING CO., LTD. (JP) 2022-12-22 US disclosed
EP-4053142-A1 EXTERNAL SKIN PREPARATION FOR AMELIORATING CELLULITE AND METHOD FOR AMELIORATING CELLULITE Toyo Sugar Refining Co., Ltd. (JP) 2022-09-07 EP disclosed
CN-114828812-A Composition comprising rose plant extract 欧莱雅 2022-07-29 CN disclosed
CN-114599341-A External skin preparation for cellulite improvement and method for improving cellulite 东洋精糖株式会社 2022-06-07 CN disclosed
CN-107997989-B Cleansing oil 株式会社芳珂 2022-05-06 CN disclosed
WO-2015093264-A1 COMPOSITION L'OREAL (FR) 2015-06-25 WO disclosed
WO-2015024079-A1 COSMETIC COMPOSITION COMPRISING AMINO SILICONES, CATIONIC SURFACTANTS AND SPECIFIC ESTERS AND A PROCESS FOR A COSMETIC TREATMENT L'OREAL (FR) 2015-02-26 WO disclosed
WO-2013190707-A1 COSMETIC COMPOSITION COMPRISING A NON VOLATILE PHENYL DIMETHICONE OIL, A NON VOLATILE HYDROCARBONATED APOLAR OIL, A NON VOLATIL HYDROCARBONATED POLAR OIL, AND A DEXTRIN ESTER L'OREAL (FR) 2013-12-27 WO disclosed
WO-2013190710-A1 COSMETIC COMPOSITION COMPRISING A NON VOLATILE DIMETHICONE OIL, A NON VOLATILE PHENYLATED SILICONE OIL AND A NON VOLATILE HYDROCARBONATED APOLAR OIL L'OREAL (FR) 2013-12-27 WO disclosed
EP-2582354-A2 AMINO ACID DERIVATIVES; COMPOSITIONS CONTAINING THEM; USE AS AGENTS FOR TREATING HUMAN PERSPIRATION L'Oréal (FR) 2013-04-24 EP disclosed
WO-2011157611-A2 AMINO ACID DERIVATIVES; COMPOSITIONS CONTAINING THEM; USE AS AGENTS FOR TREATING HUMAN PERSPIRATION L'OREAL (FR) 2011-12-22 WO disclosed
EP-1454958-B1 LACTIC ACID POLYMER COMPOSITION AND MOLDED OBJECT THEREOF NEW JAPAN CHEM CO LTD (JP) 2006-10-04 EP disclosed
US-20050001349-A1 Lactic acid polymer composition and molded object thereof NEW JAPAN CHEMICAL CO., LTD. (JP) 2005-01-06 US disclosed
EP-1454958-A1 LACTIC ACID POLYMER COMPOSITION AND MOLDED OBJECT THEREOF NEW JAPAN CHEMICAL CO.,LTD. (JP) 2004-09-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220401761-A1 Skin External Preparation for Cellulite Improvement and Cellulite Improvement Method CUTA, GANC, ENGASE DGKA 736/4885MAPT 4720/4885DNM1 1441/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.